Fabiana L. Cecere

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Journal: Cancer treatment and research communications

Published: August 25, 2026

Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].

Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 27, 2026

Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study.

Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study.

Journal: Tumori

Published: May 04, 2026

Evolving Treatment Strategies in Anal Squamous Cell Carcinoma: Integrating Chemoradiotherapy, Immunotherapy, and Emerging Biomarkers.

Evolving Treatment Strategies in Anal Squamous Cell Carcinoma: Integrating Chemoradiotherapy, Immunotherapy, and Emerging Biomarkers.

Journal: Critical reviews in oncology/hematology

Published: March 18, 2026

Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.

Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.

Journal: Journal of clinical medicine

Published: March 10, 2026

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma.

Journal: Clinical lung cancer

Published: December 28, 2025

Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Journal: Clinical and experimental medicine

Published: December 17, 2025

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 27, 2025

Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-Analysis.

Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-Analysis.

Journal: JTO clinical and research reports

Published: August 25, 2025

Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Journal: Clinical and experimental medicine

Published: May 28, 2025

Sex Differences in Health-Related Quality of Life Following Pulmonary Resection: A Systematic Review.

Sex Differences in Health-Related Quality of Life Following Pulmonary Resection: A Systematic Review.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: May 05, 2025

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

Journal: Cancer treatment and research communications

Published: March 24, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026